The aim of this update is to provide information and guidance to countries on how best to use tenofovir (TDF) for the treatment of children with HIV. It is intended to complement the World Health Organization (WHO) normative guidelines on antiretroviral therapy (ART) and also support the goal of increasing access to simpler paediatric antiretroviral (ARV) formulations, in line with Treatment 2.0.
|